| EMRYX | VEIEX | EMRYX / VEIEX | |
| Total Expense Ratio | 1.11 | 0.29 | 383% |
| Annual Report Gross Expense Ratio | 1.27 | 0.29 | 438% |
| Fund Existence | 16 years | 32 years | - |
| Gain YTD | 26.632 | 13.015 | 205% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 387M | 163B | 0% |
| Annual Yield % from dividends | 0.92 | 2.29 | 40% |
| Returns for 1 year | 49.13 | 28.29 | 174% |
| Returns for 3 years | 67.83 | 48.62 | 140% |
| Returns for 5 years | 10.43 | 25.38 | 41% |
| Returns for 10 years | 100.19 | 108.17 | 93% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TSLIX | 6.64 | 0.10 | +1.53% |
| Transamerica Small Cap Value I | |||
| PSVDX | 22.48 | 0.33 | +1.49% |
| PGIM Quant Solutions Small-Cap Val R2 | |||
| SWTSX | 18.15 | 0.20 | +1.11% |
| Schwab Total Stock Market Index | |||
| QCACX | 47.40 | 0.46 | +0.98% |
| Federated Hermes MDT All Cap Core C | |||
| MCRTX | 56.94 | 0.55 | +0.98% |
| Morgan Stanley Insight R6 | |||